KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

GoodRx Holdings (GDRX) Leases (2019 - 2025)

GoodRx Holdings' Leases history spans 7 years, with the latest figure at $28.8 million for Q4 2025.

  • For Q4 2025, Leases rose 3.65% year-over-year to $28.8 million; the TTM value through Dec 2025 reached $28.8 million, up 3.65%, while the annual FY2025 figure was $28.8 million, 3.65% up from the prior year.
  • Leases for Q4 2025 was $28.8 million at GoodRx Holdings, down from $29.7 million in the prior quarter.
  • Across five years, Leases topped out at $34.9 million in Q1 2023 and bottomed at $3.4 million in Q1 2025.
  • The 5-year median for Leases is $28.7 million (2022), against an average of $26.7 million.
  • The largest annual shift saw Leases surged 236.28% in 2023 before it plummeted 89.01% in 2025.
  • A 5-year view of Leases shows it stood at $20.2 million in 2021, then crashed by 55.94% to $8.9 million in 2022, then soared by 236.28% to $29.9 million in 2023, then fell by 7.13% to $27.8 million in 2024, then grew by 3.65% to $28.8 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Leases are $28.8 million (Q4 2025), $29.7 million (Q3 2025), and $30.7 million (Q2 2025).